QUARTERLY REPORT

Q1 2024 — Form 10-Q

Q1 2024PDF · 28 pages341 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the quarterly period ended March 31, 2024
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the transition period from ___________ to ___________
Commission File Number 001-03761
TEXAS INSTRUMENTS INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
Delaware 	75-0289970
(State of Incorporation) 	(I.R.S. Employer Identification No.)
12500 TI Boulevard, Dallas, Texas 	75243
(Address of principal executive offices) 	(Zip Code)
Registrant’s telephone number, including area code 214-479-3773
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, par value $1.00 	TXN 	The Nasdaq Global Select Market
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was
required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
910,482,146
Number of shares of Registrant’s common stock outstanding as of
April 16, 2024

-- 1 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
PART I - FINANCIAL INFORMATION
ITEM 1. Financial statements
For Three Months Ended
Consolidated Statements of Income 	March 31,
(In millions, except per-share amounts) 	2024 	2023
Revenue 	$ 	3,661 $ 	4,379
Cost of revenue (COR) 	1,566 	1,516
Gross profit 	2,095 	2,863
Research and development (R&D) 	478 	455
Selling, general and administrative (SG&A) 	455 	474
Restructuring charges/other 	(124) 	—
Operating profit 	1,286 	1,934
Other income (expense), net (OI&E) 	123 	80
Interest and debt expense 	116 	68
Income before income taxes 	1,293 	1,946
Provision for income taxes 	188 	238
Net income 	$ 	1,105 $ 	1,708
Earnings per common share (EPS):
Basic 	$ 	1.21 $ 	1.87
Diluted 	$ 	1.20 $ 	1.85
Average shares outstanding:
Basic 	910 	907
Diluted 	917 	916
A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend equivalents. Diluted EPS is
calculated using the following:
Net income 	$ 	1,105 $ 	1,708
Income allocated to RSUs 	(5) 	(9)
Income allocated to common stock for diluted EPS 	$ 	1,100 $ 	1,699
See accompanying notes.
2

-- 2 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
For Three Months Ended
Consolidated Statements of Comprehensive Income 	March 31,
(In millions) 	2024 	2023
Net income 	$ 	1,105 $ 	1,708
Other comprehensive income (loss)
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($2) and $1 	5 	(2)
Recognized within net income, net of tax effect of ($1) and ($1) 	2 	3
Derivative instruments:
Change in fair value, net of tax effect of $0 and $1 	1 	(2)
Available-for-sale investments:
Unrealized gains (losses), net of tax effect of $2 and $0 	(6) 	3
Other comprehensive income (loss), net of taxes 	2 	2
Total comprehensive income 	$ 	1,107 $ 	1,710
See accompanying notes.
3

-- 3 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
March 31, 	December 31,
Consolidated Balance Sheets 	2024 	2023
(In millions, except par value)
Assets
Current assets:
Cash and cash equivalents 	$ 	2,483 $ 	2,964
Short-term investments 	7,910 	5,611
Accounts receivable, net of allowances of ($20) and ($16) 	1,671 	1,787
Raw materials 	417 	420
Work in process 	2,129 	2,109
Finished goods 	1,537 	1,470
Inventories 	4,083 	3,999
Prepaid expenses and other current assets 	1,301 	761
Total current assets 	17,448 	15,122
Property, plant and equipment at cost 	13,739 	13,268
Accumulated depreciation 	(3,297) 	(3,269)
Property, plant and equipment 	10,442 	9,999
Goodwill 	4,362 	4,362
Deferred tax assets 	821 	757
Capitalized software licenses 	231 	223
Overfunded retirement plans 	169 	173
Other long-term assets 	1,412 	1,712
Total assets 	$ 	34,885 $ 	32,348
Liabilities and stockholders’ equity
Current liabilities:
Current portion of long-term debt 	$ 	1,349 $ 	599
Accounts payable 	551 	802
Accrued compensation 	399 	836
Income taxes payable 	378 	172
Accrued expenses and other liabilities 	876 	911
Total current liabilities 	3,553 	3,320
Long-term debt 	12,840 	10,624
Underfunded retirement plans 	111 	108
Deferred tax liabilities 	55 	63
Other long-term liabilities 	1,343 	1,336
Total liabilities 	17,902 	15,451
Stockholders’ equity:
Preferred stock, $25 par value. Shares authorized – 10; none issued 	— 	—
Common stock, $1 par value. Shares authorized – 2,400; shares issued – 1,741 	1,741 	1,741
Paid-in capital 	3,439 	3,362
Retained earnings 	52,199 	52,283
Treasury common stock at cost
Shares: March 31, 2024 – 831; December 31, 2023 – 832 	(40,193) 	(40,284)
Accumulated other comprehensive income (loss), net of taxes (AOCI) 	(203) 	(205)
Total stockholders’ equity 	16,983 	16,897
Total liabilities and stockholders’ equity 	$ 	34,885 $ 	32,348
See accompanying notes.
4

-- 4 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
For Three Months Ended
Consolidated Statements of Cash Flows 	March 31,
(In millions) 	2024 	2023
Cash flows from operating activities
Net income 	$ 	1,105 $ 	1,708
Adjustments to net income:
Depreciation 	346 	265
Amortization of capitalized software 	16 	16
Stock compensation 	106 	104
Gains on sales of assets 	(129) 	—
Deferred taxes 	(71) 	(8)
Increase (decrease) from changes in:
Accounts receivable 	116 	18
Inventories 	(84) 	(531)
Prepaid expenses and other current assets 	(24) 	(4)
Accounts payable and accrued expenses 	(77) 	(124)
Accrued compensation 	(444) 	(407)
Income taxes payable 	212 	185
Changes in funded status of retirement plans 	17 	6
Other 	(72) 	(68)
Cash flows from operating activities 	1,017 	1,160
Cash flows from investing activities
Capital expenditures 	(1,248) 	(982)
Proceeds from asset sales 	192 	1
Purchases of short-term investments 	(4,864) 	(3,013)
Proceeds from short-term investments 	2,631 	4,026
Other 	(40) 	(4)
Cash flows from investing activities 	(3,329) 	28
Cash flows from financing activities
Proceeds from issuance of long-term debt 	2,980 	1,397
Dividends paid 	(1,183) 	(1,125)
Stock repurchases 	(3) 	(103)
Proceeds from common stock transactions 	65 	85
Other 	(28) 	(15)
Cash flows from financing activities 	1,831 	239
Net change in cash and cash equivalents 	(481) 	1,427
Cash and cash equivalents at beginning of period 	2,964 	3,050
Cash and cash equivalents at end of period 	$ 	2,483 $ 	4,477
See accompanying notes.
5

-- 5 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Notes to financial statements
1. Description of business, including segment and geographic area information
We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. We have two
reportable segments, Analog and Embedded Processing, each of which represents groups of similar products that are combined on the basis
of similar design and development requirements, product characteristics, manufacturing processes and distribution channels. Our segments
also reflect how management allocates resources and measures results.
• Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying
them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded
processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing,
discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog
segment consists of two major product lines: Power and Signal Chain.
• Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific
tasks and can be optimized for various combinations of performance, power and cost, depending on the application.
We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative
thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP products,
calculators and custom ASIC products.
Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating
segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit
basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not
provided.
Segment information
For Three Months Ended
March 31,
2024 	2023
Revenue:
Analog 	$ 	2,836 $ 	3,289
Embedded Processing 	652 	832
Other 	173 	258
Total revenue 	$ 	3,661 $ 	4,379
Operating profit:
Analog 	$ 	1,008 $ 	1,574
Embedded Processing 	105 	237
Other (a) 	173 	123
Total operating profit 	$ 	1,286 $ 	1,934
(a) Includes restructuring charges/other
®
6

-- 6 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Geographic area information
Our estimate for revenue based on the geographic location of our end customers’ headquarters, which represents where critical decisions
are made, is as follows:
For Three Months Ended
March 31,
2024 	2023
Revenue:
United States 	$ 1,288 	35 % $ 1,357 	31 %
China 	623 	17 	876 	20
Rest of Asia 	401 	11 	394 	9
Europe, Middle East and Africa (a) 	955 	26 	1,270 	29
Japan 	330 	9 	438 	10
Rest of world 	64 	2 	44 	1
Total revenue 	$ 3,661 	100 % $ 4,379 	100 %
(a) Revenue from end customers headquartered in Germany was 13% in the first quarters of both 2024 and 2023.
2. Basis of presentation and significant accounting policies and practices
Basis of presentation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December
31, 2023. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended March 31, 2024 and
2023, and the Consolidated Balance Sheet as of March 31, 2024, are not audited but reflect all adjustments that are of a normal recurring
nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally included
in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and Exchange
Commission. Because the consolidated interim financial statements do not include all of the information and notes required by GAAP for a
complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes
included in our annual report on Form 10-K for the year ended December 31, 2023. The results for the three-month periods are not
necessarily indicative of a full year’s results.
Significant accounting policies and practices
Earnings per share (EPS)
We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing
nonforfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded
from the calculation of income allocated to common stock.
7

-- 7 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Computation and reconciliation of earnings per common share are as follows:
For Three Months Ended March 31,
2024 	2023
Net Income 	Shares 	EPS 	Net Income 	Shares 	EPS
Basic EPS:
Net income 	$ 	1,105 	$ 	1,708
Income allocated to RSUs 	(5) 	(9)
Income allocated to common stock 	$ 	1,100 	910 $ 	1.21 $ 	1,699 	907 $ 	1.87
Dilutive effect of stock compensation plans 	7 	9
Diluted EPS:
Net income 	$ 	1,105 	$ 	1,708
Income allocated to RSUs 	(5) 	(9)
Income allocated to common stock 	$ 	1,100 	917 $ 	1.20 $ 	1,699 	916 $ 	1.85
Potentially dilutive securities representing 14 million and 8 million shares of common stock that were outstanding during the first quarters of
2024 and 2023, respectively, were excluded from the computation of diluted earnings per common share during these periods because their
effect would have been anti-dilutive.
Derivatives and hedging
We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign
currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have
on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency
exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments.
We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total
return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the
swaps and the related deferred compensation liabilities in SG&A.
In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are
recognized in AOCI and amortized over the life of the related debt.
The results of these derivative transactions were not material. We do not use derivatives for speculative or trading purposes.
Fair values of financial instruments
The fair values of our derivative financial instruments were not material as of March 31, 2024. Our investments in cash equivalents, short-
term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The carrying
values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the
short maturity of such instruments. As of March 31, 2024, the carrying value of long-term debt, including the current portion, was
$14.19 billion, and the estimated fair value was $13.33 billion. The estimated fair value is measured using broker-dealer quotes, which are
Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.
8

-- 8 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
3. Income taxes
Provision for income taxes is based on the following:
For Three Months Ended
March 31,
2024 	2023
Taxes calculated using the estimated annual effective tax rate 	$ 	176 	$ 	276
Discrete tax items 	12 	(38)
Provision for income taxes 	$ 	188 	$ 	238
Effective tax rate 	14.5 % 	12.2 %
The effective tax rate differs from the 21% U.S. statutory corporate tax rate due to the effect of U.S. tax benefits.
4. Valuation of debt and equity investments and certain liabilities
Investments measured at fair value
Money market funds, debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes.
We classify all debt investments as available-for-sale. See Fair-value considerations. Unrealized gains and losses are recorded as an
increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses are recorded as an allowance for
credit losses with an offset recognized in OI&E in our Consolidated Statements of Income.
Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred
compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A.
Other investments
Our other investments include equity-method investments and nonmarketable investments, which are not measured at fair value. These
investments consist of interests in venture capital funds and other nonmarketable securities. Gains and losses from equity-method
investments are recognized in OI&E based on our ownership share of the investee’s financial results. Nonmarketable securities are
measured at cost with adjustments for observable changes in price or impairments. Gains and losses on nonmarketable investments are
recognized in OI&E.
9

-- 9 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Details of our investments are as follows:
March 31, 2024 	December 31, 2023
Cash and Cash
Equivalents
Short-Term
Investments
Long-Term
Investments
Cash and Cash
Equivalents
Short-Term
Investments
Long-Term
Investments
Measured at fair value:
Money market funds 	$ 	1,473 $ 	— $ 	— $ 	1,068 $ 	— $ 	—
Corporate obligations 	130 	2,322 	— 	349 	1,605 	—
U.S. government and agency securities 	174 	5,292 	— 	696 	3,808 	—
Non-U.S. government and agency
securities 	— 	296 	— 	50 	198 	—
Mutual funds 	— 	— 	11 	— 	— 	12
Total 	1,777 	7,910 	11 	2,163 	5,611 	12
Other measurement basis:
Equity-method investments 	— 	— 	13 	— 	— 	17
Nonmarketable investments 	— 	— 	4 	— 	— 	5
Total 	— 	— 	17 	— 	— 	22
Cash on hand 	706 	— 	— 	801 	— 	—
Total 	$ 	2,483 $ 	7,910 $ 	28 $ 	2,964 $ 	5,611 $ 	34
As of March 31, 2024, and December 31, 2023, unrealized gains and losses associated with our debt investments were not material. We did
not recognize any credit losses related to debt investments for the first three months of 2024 and 2023.
The following table presents the aggregate maturities of our available-for-sale debt investments as of March 31, 2024:
Fair Value
One year or less 	$ 	7,585
One to two years 	629
Proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $2.63 billion and $4.03 billion for the first
quarters of 2024 and 2023, respectively. Gross realized gains and losses from these sales were not material.
Fair-value considerations
We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in
an orderly transaction between market participants on the measurement date.
The three-level hierarchy described below indicates the extent and level of judgment used to estimate fair-value measurements.
• Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date.
10

-- 10 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
• Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation
with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not
active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require
significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by
readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for
reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in
active markets.
• Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management
judgment. These values are generally determined using pricing models that utilize management estimates of market participant
assumptions. As of March 31, 2024, and December 31, 2023, we had no Level 3 assets or liabilities.
The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on
hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value.
March 31, 2024 	December 31, 2023
Level 1 	Level 2 	Total 	Level 1 	Level 2 	Total
Assets:
Money market funds 	$ 	1,473 $ 	— $ 	1,473 $ 	1,068 $ 	— $ 	1,068
Corporate obligations 	— 	2,452 	2,452 	— 	1,954 	1,954
U.S. government and agency securities 	3,592 	1,874 	5,466 	3,618 	886 	4,504
Non-U.S. government and agency securities 	— 	296 	296 	— 	248 	248
Mutual funds 	11 	— 	11 	12 	— 	12
Total assets 	$ 	5,076 $ 	4,622 $ 	9,698 $ 	4,698 $ 	3,088 $ 	7,786
Liabilities:
Deferred compensation 	$ 	395 $ 	— $ 	395 $ 	393 $ 	— $ 	393
Total liabilities 	$ 	395 $ 	— $ 	395 $ 	393 $ 	— $ 	393
5. Postretirement benefit plans
Expenses related to defined benefit and retiree health care benefit plans are as follows:
U.S. Defined Benefit 	U.S. Retiree Health Care 	Non-U.S. Defined Benefit
For Three Months Ended March 31, 	2024 	2023 	2024 	2023 	2024 	2023
Service cost 	$ 	2 $ 	2 $ 	— $ 	— $ 	4 $ 	4
Interest cost 	6 	7 	3 	4 	14 	14
Expected return on plan assets 	(6) 	(6) 	(3) 	(5) 	(19) 	(15)
Recognized net actuarial losses (gains) 	1 	2 	(1) 	(1) 	3 	3
Net periodic benefit costs (credits) 	$ 	3 $ 	5 $ 	(1) $ 	(2) $ 	2 $ 	6
6. Debt and lines of credit
Short-term borrowings
We maintain a line of credit to provide additional liquidity through bank loans and, if necessary, to support commercial paper borrowings. As
of March 31, 2024, the aforementioned line of credit was a variable-rate, revolving credit facility from a consortium of investment-grade banks
that allows us to borrow up to $1 billion until March 2025. The interest rate on borrowings under this credit facility, if drawn, is indexed to the
applicable Term Secured Overnight Financing Rate (Term SOFR). As of March 31, 2024, our credit facility was undrawn, and we had no
commercial paper outstanding.
11

-- 11 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Long-term debt
In February 2024, we issued five series of senior unsecured notes for an aggregate principal amount of $3.00 billion, consisting of:
• $650 million of 4.60% notes due in 2027;
• $650 million of 4.60% notes due in 2029;
• $600 million of 4.85% notes due in 2034;
• $750 million of 5.15% notes due in 2054; and
• $350 million further issuance of existing 5.05% notes due in 2063.
We incurred $16 million of issuance and other related costs. The proceeds of the offering were $2.98 billion, net of the original issuance
discounts, which will be used for general corporate purposes.
Long-term debt outstanding is as follows:
March 31, 	December 31,
2024 	2023
Notes due 2024 at 2.625% 	$ 	300 $ 	300
Notes due 2024 at 4.70% 	300 	300
Notes due 2025 at 1.375% 	750 	750
Notes due 2026 at 1.125% 	500 	500
Notes due 2027 at 4.60% 	650 	—
Notes due 2027 at 2.90% 	500 	500
Notes due 2028 at 4.60% 	700 	700
Notes due 2029 at 4.60% 	650 	—
Notes due 2029 at 2.25% 	750 	750
Notes due 2030 at 1.75% 	750 	750
Notes due 2031 at 1.90% 	500 	500
Notes due 2032 at 3.65% 	400 	400
Notes due 2033 at 4.90% 	950 	950
Notes due 2034 at 4.85% 	600 	—
Notes due 2039 at 3.875% 	750 	750
Notes due 2048 at 4.15% 	1,500 	1,500
Notes due 2051 at 2.70% 	500 	500
Notes due 2052 at 4.10% 	300 	300
Notes due 2053 at 5.00% 	650 	650
Notes due 2054 at 5.15% 	750 	—
Notes due 2063 at 5.05% 	1,550 	1,200
Total debt 	14,300 	11,300
Net unamortized discounts, premiums and issuance costs 	(111) 	(77)
Total debt, including net unamortized discounts, premiums and issuance costs 	14,189 	11,223
Current portion of long-term debt 	(1,349) 	(599)
Long-term debt 	$ 	12,840 $ 	10,624
Interest and debt expense was $116 million and $68 million for the first quarters of 2024 and 2023, respectively. This was net of the
amortized discounts, premiums, issuance and other related costs. Capitalized interest was $6 million and $2 million for the first quarters of
2024 and 2023, respectively.
12

-- 12 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
7. Stockholders’ equity
Changes in equity are as follows:
Common Stock Paid-in Capital Retained
Earnings
Treasury
Common Stock 	AOCI
Balance, December 31, 2023 	$ 	1,741 $ 	3,362 $ 	52,283 $ 	(40,284) $ 	(205)
2024
Net income 	— 	— 	1,105 	— 	—
Dividends declared and paid ($1.30 per share) 	— 	— 	(1,183) 	— 	—
Common stock issued for stock-based awards 	— 	(29) 	— 	94 	—
Stock repurchases 	— 	— 	— 	(3) 	—
Stock compensation 	— 	106 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	2
Dividend equivalents on RSUs 	— 	— 	(7) 	— 	—
Other 	— 	— 	1 	— 	—
Balance, March 31, 2024 	$ 	1,741 $ 	3,439 $ 	52,199 $ 	(40,193) $ 	(203)
Common Stock Paid-in Capital Retained
Earnings Treasury
Common Stock 	AOCI
Balance, December 31, 2022 	$ 	1,741 $ 	2,951 $ 	50,353 $ 	(40,214) $ 	(254)
2023
Net income 	— 	— 	1,708 	— 	—
Dividends declared and paid ($1.24 per share) 	— 	— 	(1,125) 	— 	—
Common stock issued for stock-based awards 	— 	(37) 	— 	118 	—
Stock repurchases 	— 	— 	— 	(96) 	—
Stock compensation 	— 	104 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	2
Dividend equivalents on RSUs 	— 	— 	(6) 	— 	—
Other 	— 	(2) 	— 	— 	—
Balance, March 31, 2023 	$ 	1,741 $ 	3,016 $ 	50,930 $ 	(40,192) $ 	(252)
8. Contingencies
Indemnification guarantees
We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal,
infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.
Warranty costs/product liabilities
Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the
buyer. Product claim consideration may exceed the price of our products. Historically, we have experienced a low rate of payments on
product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse
effect on our consolidated financial statements. We accrue for known product-related claims if a loss is probable and can be reasonably
estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability.
13

-- 13 of 28 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
General
We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we
believe that the results of these proceedings will not have a material adverse effect on our consolidated financial statements.
9. Supplemental financial information
Restructuring charges/other
During the first quarter of 2024, restructuring charges/other was a credit of $124 million primarily due to a gain on the sale of a property.
Prepaid expenses and other current assets
March 31, 	December 31,
2024 	2023
U.S. CHIPS and Science Act investment tax credit 	$ 	999 $ 	497
Other 	302 	264
Total 	$ 	1,301 $ 	761
Other long-term assets
March 31, 	December 31,
2024 	2023
U.S. CHIPS and Science Act investment tax credit 	$ 	498 $ 	859
Other 	914 	853
Total 	$ 	1,412 $ 	1,712
Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income
Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income during the first quarters
of 2024 and 2023. The table below details where these transactions are recorded in our Consolidated Statements of Income.
For Three Months Ended
Impact to Related Statement of Income
Lines
March 31,
2024 	2023
Net actuarial losses of defined benefit plans:
Recognized net actuarial losses (a) 	$ 	3 $ 	4 Decrease to OI&E
Tax effect 	(1) 	(1)
Decrease to provision for income
taxes
Recognized within net income, net of taxes 	$ 	2 $ 	3 Decrease to net income
(a) Detailed in Note 5
Effect on shares outstanding and treasury shares
The following table reflects the changes in treasury shares:
2024
Balance, January 1 	832
Repurchases 	—
Shares issued for stock compensation 	(1)
Balance, March 31 	831
14

-- 14 of 28 --

ITEM 2. Management’s discussion and analysis of financial condition and results of operations
Overview
We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. Technology is the
foundation of our company, but ultimately, our objective and the best metric for owners to measure our progress is through the growth of free
cash flow per share over the long term.
Our strategy to maximize long-term free cash flow per share growth has three elements:
1. A great business model that is focused on analog and embedded processing products and built around four sustainable competitive
advantages. The four sustainable competitive advantages are powerful in combination and provide tangible benefits:
i. A strong foundation of manufacturing and technology that provides lower costs and greater control of our supply chain.
ii. A broad portfolio of analog and embedded processing products that offers more opportunity per customer and more value for
our investments.
iii. The reach of our market channels that gives access to more customers and more of their design projects, leading to the
opportunity to sell more of our products into each design and gives us better insight and knowledge of customer needs.
iv. Diversity and longevity of our products, markets and customer positions that provide less single point dependency and longer
returns on our investments.
Together, these competitive advantages help position TI in a unique class of companies capable of generating and returning
significant amounts of cash for our owners. We make our investments with an eye towards long-term strengthening and leveraging of
these advantages.
2. Discipline in allocating capital to the best opportunities. This spans how we select R&D projects, develop new capabilities like
TI.com, invest in new manufacturing capacity or how we think about acquisitions and returning cash to our owners.
3. Efficiency, which means constantly striving for more output for every dollar spent.
We believe that our business model with the combined effect of our four competitive advantages sets TI apart from our peers and will for a
long time to come. We will invest to strengthen our competitive advantages, be disciplined in capital allocation and stay diligent in our pursuit
of efficiencies. Finally, we will remain focused on the belief that long-term growth of free cash flow per share is the ultimate measure to
generate value.
Management’s discussion and analysis of financial condition and results of operations (MD&A) should be read in conjunction with the
financial statements and the related notes that appear elsewhere in this document. In the following discussion of our results of operations:
• Our segments represent groups of similar products that are combined on the basis of similar design and development requirements,
product characteristics, manufacturing processes and distribution channels, and how management allocates resources and measures
results. See Note 1 to the financial statements for more information regarding our segments.
• When we discuss our results:
◦ Unless otherwise noted, changes in our revenue are attributable to changes in customer demand, which are evidenced by
fluctuations in shipment volumes.
◦ New products do not tend to have a significant impact on our revenue in any given period because we sell such a large
number of products.
◦ From time to time, our revenue and gross profit are affected by changes in demand for higher-priced or lower-priced
products, which we refer to as changes in the “mix” of products shipped.
15

-- 15 of 28 --

◦ Because we own much of our manufacturing capacity, a significant portion of our operating cost is fixed. When factory
loadings decrease, our fixed costs are spread over reduced output and, absent other circumstances, our profit margins
decrease. Conversely, as factory loadings increase, our fixed costs are spread over increased output and, absent other
circumstances, our profit margins increase.
• For an explanation of free cash flow, see the Non-GAAP financial information section.
• All dollar amounts in the tables are stated in millions of U.S. dollars.
Performance summary
Our first quarter revenue was $3.66 billion, net income was $1.11 billion and earnings per share (EPS) were $1.20.
Revenue decreased 16% from the same quarter a year ago and 10% sequentially, as revenue declined across all end markets.
Our cash flow from operations of $6.3 billion for the trailing 12 months again underscored the strength of our business model, the quality of
our product portfolio and the benefit of 300mm production. Free cash flow for the same period was $940 million.
Over the past 12 months we invested $3.7 billion in R&D and SG&A, invested $5.3 billion in capital expenditures and returned $4.8 billion to
shareholders.
Results of operations – first quarter 2024 compared with first quarter 2023
Revenue of $3.66 billion decreased $718 million, or 16%, primarily due to lower revenue from Analog and, to a lesser extent, Embedded
Processing.
Gross profit of $2.10 billion was down $768 million, or 27%, primarily due to lower revenue and, to a lesser extent, higher manufacturing
costs associated with reduced factory loadings and our planned capacity expansions. As a percentage of revenue, gross profit decreased to
57.2% from 65.4%.
Operating expenses (R&D and SG&A) were $933 million compared with $929 million.
Restructuring charges/other was a credit of $124 million primarily due to a gain on the sale of a property during 2024.
Operating profit was $1.29 billion, or 35.1% of revenue, compared with $1.93 billion, or 44.2% of revenue.
OI&E was $123 million of income compared with $80 million of income, primarily due to higher interest income.
Interest and debt expense of $116 million increased $48 million due to the issuance of additional long-term debt. See Note 6 to the financial
statements.
Our provision for income taxes was $188 million compared with $238 million. This decrease was due to lower income before income taxes,
partially offset by discrete tax items.
Net income was $1.11 billion compared with $1.71 billion. EPS was $1.20 compared with $1.85.
16

-- 16 of 28 --

First quarter 2024 segment results
Our segment results compared with the year-ago quarter are as follows:
Analog (includes Power and Signal Chain product lines)
Q1 2024 	Q1 2023 	Change
Revenue 	$ 	2,836 	$ 	3,289 	(14)%
Operating profit 	1,008 	1,574 	(36)%
Operating profit % of revenue 	35.5 % 	47.9 %
Analog revenue decreased in both product lines, led by Signal Chain. Operating profit decreased primarily due to lower revenue and higher
manufacturing costs.
Embedded Processing (includes microcontrollers and processors)
Q1 2024 	Q1 2023 	Change
Revenue 	$ 	652 	$ 	832 	(22)%
Operating profit 	105 	237 	(56)%
Operating profit % of revenue 	16.1 % 	28.5 %
Embedded Processing revenue decreased. Operating profit decreased primarily due to lower revenue and associated gross profit.
Other (includes DLP products, calculators and custom ASIC products)
Q1 2024 	Q1 2023 	Change
Revenue 	$ 	173 	$ 	258 	(33)%
Operating profit* 	173 	123 	41 %
Operating profit % of revenue 	100.0 % 	47.7 %
* Includes restructuring charges/other
Other revenue decreased $85 million, and operating profit increased $50 million.
Financial condition
At the end of the first quarter of 2024, total cash (cash and cash equivalents plus short-term investments) was $10.39 billion, an increase of
$1.82 billion from the end of 2023.
Accounts receivable were $1.67 billion, a decrease of $116 million compared with the end of 2023. Days sales outstanding for the first
quarter of 2024 were 41 compared with 39 at the end of 2023.
Inventory was $4.08 billion, an increase of $84 million from the end of 2023. Days of inventory for the first quarter of 2024 were 235
compared with 219 at the end of 2023.
Liquidity and capital resources
Our primary source of liquidity is cash flow from operations. Additional sources of liquidity are cash and cash equivalents, short-term
investments and access to debt markets. We also have a variable-rate, revolving credit facility. As of March 31, 2024, our credit facility was
undrawn, and we had no commercial paper outstanding. Cash flows from operating activities for the first three months of 2024 were
$1.02 billion, a decrease of $143 million from the year-ago period primarily due to lower net income, partially offset by lower cash used for
working capital.
Investing activities for the first three months of 2024 used $3.33 billion compared with $28 million of cash provided in the year-ago period.
Capital expenditures were $1.25 billion compared with $982 million in the year-ago period and were primarily for semiconductor
manufacturing equipment and facilities in both periods. Short-term investments used cash of $2.23 billion compared with $1.01 billion of cash
provided in the year-ago period.
®
17

-- 17 of 28 --

As we continue to invest to strengthen our competitive advantage in manufacturing and technology as part of our long-term capacity
planning, our capital expenditures are expected to remain at elevated levels. In August 2022, the U.S. government enacted the U.S. CHIPS
and Science Act, which provides funding for manufacturing grants and research investments and establishes a 25% investment tax credit for
certain investments in U.S. semiconductor manufacturing. We will begin receiving the cash benefit associated with the investment tax credit
for qualifying capital expenditures in the second quarter of 2024. See Note 9 to the financial statements. We have also submitted applications
for the manufacturing grants provided by the legislation.
Financing activities for the first three months of 2024 provided $1.83 billion compared with $239 million in the year-ago period. In 2024, we
received net proceeds of $2.98 billion from the issuance of fixed-rate, long-term debt. In the year-ago period, we received net proceeds of
$1.40 billion from the issuance of fixed-rate, long-term debt. Dividends paid were $1.18 billion compared with $1.13 billion in the year-ago
period, reflecting an increased dividend rate. We used $3 million to repurchase shares of our common stock compared with $103 million in
the year-ago period. Employee exercises of stock options provided cash proceeds of $65 million compared with $85 million in the year-ago
period.
We had $2.48 billion of cash and cash equivalents and $7.91 billion of short-term investments as of March 31, 2024. We believe we have the
necessary financial resources and operating plans to fund our working capital needs, capital expenditures, dividend and debt-related
payments, and other business requirements for at least the next 12 months.
Non-GAAP financial information
This MD&A includes references to free cash flow and ratios based on that measure. These are financial measures that were not prepared in
accordance with generally accepted accounting principles in the United States (GAAP). Free cash flow was calculated by subtracting capital
expenditures from the most directly comparable GAAP measure, cash flows from operating activities (also referred to as cash flow from
operations).
We believe that free cash flow and the associated ratios provide insight into our liquidity, our cash-generating capability and the amount of
cash potentially available to return to shareholders, as well as insight into our financial performance. These non-GAAP measures are
supplemental to the comparable GAAP measures.
Reconciliation to the most directly comparable GAAP measures is provided in the table below.
For 12 Months Ended
March 31,
2024 	2023 	Change
Cash flow from operations (GAAP) 	$ 	6,277 	$ 	7,736 	(19)%
Capital expenditures 	(5,337) 	(3,336)
Free cash flow (non-GAAP) 	$ 	940 	$ 	4,400 	(79)%
Revenue 	$ 	16,801 	$ 	19,502
Cash flow from operations as a percentage of revenue (GAAP) 	37.4 % 	39.7 %
Free cash flow as a percentage of revenue (non-GAAP) 	5.6 % 	22.6 %
18

-- 18 of 28 --

ITEM 4. Controls and procedures
An evaluation as of the end of the period covered by this report was carried out under the supervision and with the participation of
management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based upon
that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that those disclosure controls and procedures were
effective. In addition, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f)
under the Securities Exchange Act of 1934) that occurred during the period covered by this report that has materially affected, or is
reasonably likely to materially affect, our internal control over financial reporting.
19

-- 19 of 28 --

PART II – OTHER INFORMATION
ITEM 1A. Risk factors
Information concerning our risk factors is contained in Item 1A of our Form 10-K for the year ended December 31, 2023, and is incorporated
by reference herein.
ITEM 2. Unregistered sales of equity securities and use of proceeds
The following table contains information regarding our purchases of our common stock during the quarter.
ISSUER PURCHASES OF EQUITY SECURITIES
Period Total Number of Shares
Purchased
Average Price
Paid per Share
Total Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs (a)
Approximate Dollar Value
of Shares that May Yet Be
Purchased Under the Plans
or Programs (a)
January 1, 2024 through January 31, 2024 	206,420 	$ 162.04 	1,323 	$ 21.20 billion
February 1, 2024 through February 29, 2024 	17,106 	158.65 	17,106 	21.19 billion
March 1, 2024 through March 31, 2024 	— 	— 	— 	21.19 billion
Total 	223,526 (b) 	$ 161.78 (b) 	18,429 	$ 21.19 billion (c)
(a) All open-market purchases during the quarter were made under the authorizations from our board of directors to purchase up to $12.0
billion and $15.0 billion of additional shares of TI common stock announced September 20, 2018, and September 15, 2022, respectively.
(b) In addition to open-market purchases, 205,097 shares of common stock were surrendered by employees to satisfy tax withholding
obligations in connection with the vesting of restricted stock units.
(c) As of March 31, 2024, this amount consisted of the remaining portion of the $12.0 billion authorized in September 2018 and the $15.0
billion authorized in September 2022. No expiration date has been specified for these authorizations.
20

-- 20 of 28 --

ITEM 6. Exhibits
Designation of Exhibits in
This Report 	Description of Exhibit
3(a) Restated Certificate of Incorporation of the Registrant, dated April 18, 1985, as amended (incorporated by reference
to Exhibit 3(a) of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2014).
3(b) By-Laws of the Registrant (incorporated by reference to Exhibit 3 of the Registrant’s Current Report on Form 8-K
filed January 26, 2022).
4(a) Officers’ Certificate, dated February 8, 2024 (incorporated by reference to Exhibit 4.1 of the Registrant’s Current
Report on Form 8-K filed February 8, 2024).
31(a) 	Certification of Chief Executive Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
31(b) 	Certification of Chief Financial Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
32(a) 	Certification by Chief Executive Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
32(b) 	Certification by Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
101.ins XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL
tags are embedded within the Inline XBRL document.†
101.def 	XBRL Taxonomy Extension Definition Linkbase Document.†
101.sch 	XBRL Taxonomy Extension Schema Document.†
101.cal 	XBRL Taxonomy Extension Calculation Linkbase Document.†
101.lab 	XBRL Taxonomy Extension Label Linkbase Document.†
101.pre 	XBRL Taxonomy Extension Presentation Linkbase Document.†
104 	Cover Page Interactive Data File (embedded within the Inline XBRL document).†
† Filed or furnished herewith.
21

-- 21 of 28 --

Notice regarding forward-looking statements
This report includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as TI or its management
“believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements
herein that describe TI’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such
forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in
forward-looking statements.
We urge you to carefully consider the following important factors that could cause actual results to differ materially from the expectations of TI
or our management:
• Economic, social and political conditions, and natural events in the countries in which we, our customers or our suppliers operate,
including global trade policies;
• Market demand for semiconductors, particularly in the industrial and automotive markets, and customer demand that differs from
forecasts;
• Our ability to compete in products and prices in an intensely competitive industry;
• Evolving cybersecurity and other threats relating to our information technology systems or those of our customers, suppliers and
other third parties;
• Our ability to successfully implement and realize opportunities from strategic, business and organizational changes, or our ability to
realize our expectations regarding the amount and timing of associated restructuring charges and cost savings;
• Our ability to develop, manufacture and market innovative products in a rapidly changing technological environment, our timely
implementation of new manufacturing technologies and installation of manufacturing equipment, and our ability to realize expected
returns on significant investments in manufacturing capacity;
• Availability and cost of key materials, utilities, manufacturing equipment, third-party manufacturing services and manufacturing
technology;
• Our ability to recruit and retain skilled personnel, and effectively manage key employee succession;
• Product liability, warranty or other claims relating to our products, software, manufacturing, delivery, services, design or
communications, or recalls by our customers for a product containing one of our parts;
• Compliance with or changes in the complex laws, rules and regulations to which we are or may become subject, or actions of
enforcement authorities, that restrict our ability to operate our business or subject us to fines, penalties or other legal liability;
• Changes in tax law and accounting standards that impact the tax rate applicable to us, the jurisdictions in which profits are
determined to be earned and taxed, adverse resolution of tax audits, increases in tariff rates, and the ability to realize deferred tax
assets;
• Financial difficulties of our distributors or semiconductor distributors’ promotion of competing product lines to our detriment; or
disputes with current or former distributors;
• Losses or curtailments of purchases from key customers or the timing and amount of customer inventory adjustments;
• Our ability to maintain or improve profit margins, including our ability to utilize our manufacturing facilities at sufficient levels to cover
our fixed operating costs, in an intensely competitive and cyclical industry and changing regulatory environment;
• Our ability to maintain and enforce a strong intellectual property portfolio and maintain freedom of operation in all jurisdictions where
we conduct business; or our exposure to infringement claims;
• Instability in the global credit and financial markets; and
• Impairments of our non-financial assets.
22

-- 22 of 28 --

For a more detailed discussion of these factors, see the Risk factors discussion in Item 1A of our most recent Form 10-K. The forward-
looking statements included in this report are made only as of the date of this report, and we undertake no obligation to update the forward-
looking statements to reflect subsequent events or circumstances. If we do update any forward-looking statement, you should not infer that
we will make additional updates with respect to that statement or any other forward-looking statement.
23

-- 23 of 28 --

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
TEXAS INSTRUMENTS INCORPORATED
By: 	/s/ Rafael R. Lizardi
Rafael R. Lizardi, Senior Vice President and Chief
Financial Officer
Date: April 24, 2024

-- 24 of 28 --

Exhibit 31(a)
CERTIFICATIONS
I, Haviv Ilan, certify that:
1. 	I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s
most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. 	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the
equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.
Date: April 24, 2024
/s/ Haviv Ilan
Haviv Ilan
President and
Chief Executive Officer

-- 25 of 28 --

Exhibit 31(b)
CERTIFICATIONS
I, Rafael R. Lizardi, certify that:
1. 	I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the
equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.
Date: April 24, 2024
/s/ Rafael R. Lizardi
Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

-- 26 of 28 --

Exhibit 32(a)
Certification of Periodic Report
Pursuant to 18 U.S.C. Section 1350
For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned,
Haviv Ilan, President and Chief Executive Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that, to his knowledge:
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2024, as filed with the Securities and Exchange
Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
the Company.
Dated: April 24, 2024
/s/ Haviv Ilan
Haviv Ilan
President and
Chief Executive Officer

-- 27 of 28 --

Exhibit 32(b)
Certification of Periodic Report
Pursuant to 18 U.S.C. Section 1350
For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned,
Rafael R. Lizardi, Senior Vice President and Chief Financial Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that,
to his knowledge:
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2024, as filed with the Securities and Exchange
Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
the Company.
Dated: April 24, 2024
/s/ Rafael R. Lizardi
Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

-- 28 of 28 --